News
Lazar Partners' communications experts will help your stakeholders realize the value of your hard-earned achievements and milestones through powerful writing that gets your company noticed. Our extensive experience working with biotech and medical device companies enables us to give your story the best angle for even the most discerning news arbiters. This section contains a variety of recent press releases that highlight our ability to present complex medical and commercial stories in easy to digest formats. From the most complex proof of concept data to regulatory milestones, quarterly earnings, disease awareness initiatives and beyond, we will find the best way to present your news for optimal uptake and recognition.
News

@lazarpartners

Lazar Partners Retweeted
RT @CymaBay: CymaBay’s research is focused on developing therapies for rare #liverdiseases and other chronic diseases with a high unmet med…
4:53 PM Sep 16th
Lazar Partners Retweeted
RT @achievelifesci: $ACHV management will be hosting virtual one-on-one meetings with investors throughout the @lakestreetcm 5th Annual Bes…
4:53 PM Sep 16th
Lazar Partners Retweeted
RT @achievelifesci: Today at the @SRNT_Europe Annual Meeting, $ACHV’s VP of Clinical Research, Dan Cain, presented data on the cessation be…
4:53 PM Sep 16th
Lazar Partners Retweeted
RT @VanquaBio: Vanqua Bio is pleased to announce we have closed an $85 million Series B financing round, led by Omega Funds. We’re excited…
2:30 PM Sep 14th